Stem cells in severe infantile spinal muscular atrophy (SMA1)

Neuromuscular Disorders

Volumn 22, Issue 11, 2012, Pages 1032-1034

  Carrozzi, Marco ^a   Amaddeo, Alessandro ^a   Biondi, Andrea ^b   Zanus, Caterina ^a   Monti, Fabrizio ^c   Alessandro, Ventura ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; CELL DIFFERENTIATION; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; LETTER; MALE; MESENCHYMAL STEM CELL; MOTONEURON; MOTOR PERFORMANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SPINAL CORD INJURY; WERDNIG HOFFMANN DISEASE;

HUMANS; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT OUTCOME;

EID: 84868156630     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.09.005     Document Type: Letter

References (12)

1. Joyce N., Annett G., Wirthlin L., Olson S., Bauer G., Nolta Ja Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 2010, 5(6):933-946.
2. Karussis D., Karageorgiou C., Vaknin-Dembinsky A., et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010, 67:1187-1194.
3. Lim J.Y., Jeong C.H., Jun J.A., et al. Therapeutic effects of human umbilical cord blood derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther 2011, 22:38.
4. Boucherie C., Schäfer S., Lavand'homme P., Maloteaux J.M., Hermans E. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J Neurosci Res 2009, 87:2034-2046.
5. Vercelli A., Mereuta O.M., Garbossa D., et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2008, 31:395-405.
6. Mazzini L., Mareschi K., Ferrero I., et al. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study. Cytotherapy 2012, 14:56-60.
7. Kumar A.A., Kumar S.R., Narayanan R., Arul K., Baskaran M. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I/II clinical safety and primary efficacy data. Exp Clin Transplant 2009, 7(4):241.
8. Pal R., Venkataramana N.K., Bansal A., et al. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy 2009, 11(7):897-911.
9. Callera F., do Nascimento R. Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. Exp Hematol 2006, 34(2):130-131.
10. Bae J.S., Han H.S., Youn D.H., et al. Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration. Stem Cells 2007, 25(5):1307-1316.
11. Glanzman A.M., Mazzone E., Main M., et al. The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability. Neuromuscul Disord 2010, 20(3):155-161.
12. Dubowitz V. Chaos in the classification of SMA: a possible resolution. Neuromuscul Disord 1995, 5:3-5.